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As a dreadful complication after the mechanical heart valve replacement, prosthetic valve obstruction caused by
pannus formation occurs increasingly with time. The authors here present a case of 42-year-old woman who was
urgently admitted to hospital with acute heart failure symptoms due to the mechanical mitral valve failure only
3 months after surgery. Transthoracic and transesophageal echocardiography demonstrated that the bileaflet of the
mitral prosthesis were completely immobilized with only a small transvalvular jet remained. During the reoperation,
the reason of the prosthetic valve obstruction was attributed to the noncircular pannus ingrowth extending from
the atrioventricular side. For a better understanding of the prosthetic valve dysfunction caused by pannus
formation, the authors then compile a literature review to briefly discuss the status quo of the clinical characteristics
of this uncommon complication.Background
The evolving design and biomaterials of the mechanical
heart valves have greatly advanced their in vivo
hemodynamic features and durability over decades [1].
However, the anticipated performances of the mechan-
ical prostheses are still compromised by the occurrence
of various complications, among which pannus-induced
prosthetic valve dysfunction (PVD) is relatively uncom-
mon but sometimes is the most serious one [2,3]. In par-
ticular, patients with prosthetic valve obstruction (PVO)
due to pannus ingrowth may rapidly develop hemo-
dynamic deterioration and crash into a life-threatening
condition. According to recent studies [2,4-7], the
prevalence of pannus formation in aortic or mit-
ral position is controversial. However, pannus is un-
doubtedly of later clinical onset than the thrombosis,
which is mostly responsible for the early PVD. More-
over, the duration from time of prostheses implant-
ation to pannus-induced PVD is widely variable and
has been reported to be at least 6 months to
12 months, during which an ingrowth of periannular
tissue would gradually immobilize the moving element
of the prostheses [6-8]. Here we present a rare case* Correspondence: drguoyq@hotmail.com
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reproduction in any medium, provided the orof PVO in the mitral position caused by early pannus
formation only 3 months after surgery.
Case presentation
A 42-year-old woman was admitted to our intensive car-
diac care unit with symptoms of acute left heart failure.
Three months prior to admission, she underwent the
implantation of a mechanical bileaflet mitral valve
(25 mm SJM Master; St. Paul, MN, USA) due to severe
rheumatic valve stenosis. No native valve- or chordal-
sparing procedures were performed during the replace-
ment. The postoperative course went smoothly and
transthoracic echocardiography (TTE) showed proper
functioning of the prosthesis. The patient then followed
adequate anticoagulation treatment with wafarin and the
international normalized ratio maintained above 2.0. No
episode of atrial fibrillation and other risk factors for
thrombus formation were identified. One week before
this admission, she had noticed a progressive physical
deterioration. After the treatment at local hospital, the
patient showed no signs of recovery and finally pre-
sented with severe shortness of breath and coughing up
pink, foamy mucus on the arrival of our hospital.
On admission, the patient was conscious but presented
with marked respiratory distress. Initial vital signs
showed blood pressure 80/40 mmHg, sinus rhythm, a
regular pulse of 140 beats/min and a respiratory rate of
40 breaths/min. Auscultation of the chest revealed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Echocardiography of mitral prosthesis: A) Transthoracic echo reveals immobilization of the mechanical bileaflet with
accelerated velocity of transvalvular blood flow; B) and C) Intraoperative transesophageal echo demonstrated prosthetic valve
obstruction due to pannus formation (asterisks) on atrioventricular side. LA indicates left atrium; LV indicates left ventricle.
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tinct heart murmurs. No signs of jugular venous disten-
tion and extremities edema were observed. The patient
was intubated due to the deteriorated respiratory status.
After intubation, bedside TTE demonstrated that the
prosthetic bileaflet was immobilized and only a small
transvalvular jet was observed. However, no paravalvular
leakage, and vegetations or periannular abscesses that in-
dicating endocarditis were identified (Figure 1A).
In view of the patient’s unstable hemodynamic con-
ditions and echocardiographic findings, an emergent
surgical intervention was performed. Intraoperative
transesophageal echocardiography (TEE) demonstrated
the immobilization of the prosthetic leaflets, which
might be attributed to the acoustic shadowing around
the valve ring (Figure 1B and Figure 1C). During sur-
gical inspection, a noncircular fibrotic tissue ingrowth
from the atrioventricular side was detected. The
invaded pannus strictly adhered to the valve pivots
and arrested both prosthetic leaflets (Figure 2). TheFigure 2 A macroscopic view of explanted St. Jude prosthetic valve w
aspect.failed prosthesis was explanted and a new 27 mm SJM
Master mechanical valve was implanted. The post-
operative course was regular and in-hospital TTE
showed normal functioning of the newly implanted mi-
tral prosthesis. The patient had an uneventful recovery
and was discharged home at two weeks after surgery.
On microscopic examination (Figure 3), the resected
pannus tissue was found to be mainly constituted with
infiltrated leukocytes (neutrophils, macrophages, lym-
phocytes and plasma cells), pleomorphic spindle cells
such as myofibroblasts, and interspersed capillary
vessels.
Discussion
As an exuberant healing process in response to the
implanted prosthesis, pannus formation occurs increas-
ingly with time. Compared with valvular thrombosis,
pannus is less frequently found to be an etiologic factor
that contributes to the early PVD [2-8]. According to
multiple clinical observations (Table 1), the durationith pannus ingrowth (asterisks): A) Atrial aspect; B) Ventricular
Figure 3 Histologic section shows that the specimen largely
consist of infiltrated leukocytes (arrow) and pleomorphic
spindle cells such as myofibroblasts (arrowheads), as well as
interspersed capillary vessels. Magnification× 200.
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induced PVD varies widely and has been reported to be
1.8 years to 23 years after surgery [4-7,9,10], and a
shorter time interval (6 months) has been described in
patient with the prosthetic aortic valve [8]. However, in
this case, the time interval from the initial replacement
to PVO caused by pannus ingrowth was extraordinarily
short. To our best knowledge, there were no reports of
pannus-induced PVO within one year after mitral valve
replacement [11].
The cause of the pannus-related PVD and PVO is gen-
erally considered as a chronic foreign body reaction to
the prosthetic biomaterials. It is likely that an individualTable 1 Studies of mechanical prosthetic valves obstruction d
Authors, years, [Ref.] Type of studies Position of Valves I
Vitale et al. , 1997, [4] Case series (n = 1878) Mitral valves 3
Barbetseas et al. , 1998, [6] Case series (n = 23) Mitral &Aortic valves M
p




Teshima et al. , 2003, [5] Case series (n = 615) Aortic valves 1
Sakamoto et al. , 2006, [9] Case series (n = 390) Aortic valves 1
Kondruweit et al. 2008, [8] A case report Aortic valve 6
Mullenix et al. , 2008, [3] A case report Aortic valve 1
Hurwitz et al. , 2009, [2] A case report Aortic valve 8
Khan et al. , 2009, [12] A case report Mitral valve 7
Matsuyama et al. 2011, [11] A case report Mitral valve 2
Park et al. , 2011, [13] A case report Mitral valve 9patient’s inherent propensity with coexisting risk factors
triggers and accelerates the progression of pannus for-
mation. These associated factors can be summarized as
follows: 1) Clinical characteristics of the patients: female,
concomitant endocarditis and pregnancy, the history of
rheumatic fever and valvular thrombosis, atrial fibrilla-
tion, low-output conditions, small valve annulus and in-
adequate anticoagulation [2,5-9] Design and biomaterials
of the prostheses: tilting disc valves and caged-disk/ball
valves due to low transvalvular flow [7,11,14], the pro-
truding design of the pivot guard systems in the SJM
valves [3,15] Surgical techniques: preservation of the na-
tive valve or subvalvular chordae [12,13], implantation of
the prostheses with smaller size [9], the presence of peri-
annular endothelial irregularities after implantation
[2,4,7]. Taken together, as presented in our case, the his-
tory of severe rheumatic disease, small mitral annulus
and implanted SJM prosthesis in this female patient may
have contributed to the acute formation of the pannus.
The underlying mechanism of the pannus formation
was supposed to be the significant proliferation and de-
position of myofibroblasts, phagocytes and extracellular
matrix, which are mediated by increased expression of
transforming growth factor type beta-1 (TGF-β1) in
perivalvular tissue and circulating blood [5,16]. More-
over, some studies have suggested that the persistent re-
lease of fibroblast growth factor-2 (FGF-2) from the
injured periannular tissue may also contribute to this
chronic healing process [17]. Therefore, echo to these
important observations, a promising therapeutic strat-
egy to prevent pannus formation in high risk patients
might be achieved by suppressing the proliferative
responses in periannular tissues with the drug-coated
prostheses.
The obstruction of prosthetic valves is largely caused
by pannus, thrombus or both, so it is of great thera-
peutic implications to make differential diagnosis onue to pannus formation
ncidence & Time Interval Risk Factors
.5%, Mean≥ 4 years Female, Tilting-disc valves, Bileaflet valves
ore common in aortic




Tilting-disc valves, Caged-disk/ball valves
.95%, Mean= 83± 52 months Inadequate anticoagulation, SJM valves
.8%, Mean= 10± 7.9 years Small prostheses size Turbulent Flow
months Small prosthesis size, Rheumatic fever
5 years Female, A tilting-disc valve
years Female, Endocarditis
years Female, Subvalvular chordae preservation
7 months Inadequate anticoagulation, female
years Female, Subvalvular chordae preservation
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valve replacement or resection of the ingrowth tissue
[13], is the only option for managing the pannus-
induced PVO, while thrombolytic therapy can serve as
an alternative treatment in selected patients with throm-
bosed prostheses [18,19]. As reported in several echocar-
diographic studies, pannus in situ presents with a higher
ultrasound-intensity ratio (>0.7) [6] and is usually found
to be a fixed lesion that attaches to the prosthetic ring
[2]. Conversely, the thrombotic mass demonstrated in
echo is mobile and is generally attaching to the valve
occluder [1,2,20]. Although thrombolysis may be pre-
ferred for its less invasiveness in certain group of
patients, surgical intervention, as for this case, should be
unhesitatingly performed once the patients show any
signs of hemodynamic instability.
Conclusions
With adequate anticoagulation and no preservation of
subvalvular tissue in the first-time mitral valve replace-
ment, the pannus-induced obstruction of an SJM bileaf-
let mechanical valve within such a short time interval
was very uncommon. This rare case has added to a
growing body of literatures describing the various clin-
ical features of the pannus-related PVO. Further
explorations on etiologic-specified prevention, and effi-
cient treatment for this complication are required.
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